# Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease

> **NCT07570836** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Interstitial Lung Disease (ILD)

## Interventions

- **BIOLOGICAL:** Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (hUCMSC-EVs)
- **BIOLOGICAL:** Normal Saline Placebo

## Key facts

- **NCT ID:** NCT07570836
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2027-04-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07570836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07570836, "Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07570836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*